Cellular Morphology and Motility Defects are Conserved Phenotypes of Trisomy 21 Despite Heterogeneous Adhesion Mechanisms
Katelyn RygeliD, K. ChambersiD, Brian Yoon, Manasi AgrawaliD, Samantha Bailey, Mitesh Patel, Cayla WolfeiD, Anna R Montazzoli, Taylor Bumbledare, Paige Cassidy Malcom, Shelby Kelemen, Connor NeifertiD, Jordan A. HeadeniD, Leah J. KershneriD, Nikita KirkiseiD, Kristy WelshhansiD
Abstract
Down syndrome is a neurodevelopmental disorder caused by the trisomy of human chromosome 21 (T21). Down syndrome is associated with a wide range of variable clinical features, including congenital heart defects and slow wound healing; however, intellectual disability is ubiquitous and results, in part, from altered neuronal connectivity. Here, we used three sets of control and T21 human fibroblasts, and one set of human induced pluripotent stem cell (hiPSC)-derived cortical neurons, to examine whether changes in cellular morphology and motility are consistent across cell types in Down syndrome and to elucidate the underlying mechanisms. We found that fibroblast morphology is dysregulated in all T21 fibroblast lines. Using a transwell migration assay, cellular migration is decreased in two of the three T21 fibroblast lines. T21 hiPSC-derived cortical neurons also exhibit morphological defects, including a decrease in the length of the longest neurite and growth cone area. Because of these significant changes in morphology and motility in T21 cells, we examined proteins in the focal adhesion complex, which links the intracellular cytoskeleton to the extracellular matrix and directly controls these processes. Multiple proteins in the adhesion complex, including paxillin, vinculin, talin, and RACK1, are dysregulated in T21 fibroblasts and hiPSC-derived neurons, but these changes have high inter-individual variability. Taken together, these findings suggest that altered cellular morphology and motility are conserved features of Down syndrome that arise through heterogeneous alterations in adhesion networks. Thus, this work significantly contributes to the recent literature highlighting the need for personalized medicine in Down syndrome.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Abnormal neuronal and synaptic morphology in Down syndrome brains reproduces in human isogenic cellular models
Ante Plećaš, Gillian Gough, … Ivan Alić·Cell Death and DiseasePeer-reviewed·Jun 10, 2026
- Consequences of aneuploidy in human fibroblasts with trisomy 21
S. Hwang, P. Cavaliere, … E. M. Torres·bioRxiv·Aug 14, 2020
- Trisomy 21 impairs synchronized activity and connectivity in developing human Down syndrome cortical excitatory neuron networks
Manuel Peter, Raquel Real, … Frederick J. Livesey·bioRxiv·Dec 27, 2024
- Chromosome silencing in vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling
Jennifer E. Moon, Jeanne Bentley Lawrence·Cell ReportsPeer-reviewed·Aug 1, 2022
- Synaptic and intrinsic membrane defects disrupt early neural network dynamics in Down syndrome
Saad B. Hannan, Ivan Alić, … Trevor G. Smart·Nature CommunicationsPeer-reviewed·Jan 22, 2026
- DYT1 dystonia patient-derived fibroblasts have increased deformability and susceptibility to damage by mechanical forces.
N. K. Gill, C. Ly, … A. C. Rowat·bioRxiv·Nov 28, 2018